Methods: Edaravone injection of the quality of research.
方法：对依达拉奉注射液的质量进行研究。
Boda makes the only other injected edaravone available in China.
在中国，博大药业生产了唯一的另一种依达拉奉注射液。
Results: Edaravone injection of the indicators meet the requirements.
结果：依达拉奉注射液的各项指标达到要求。
Conclusion It is effective to use edaravone in treatment of acute medium brain injure.
结论依达拉奉对治疗中度颅脑损伤患者有一定疗效。
Conclusion Edaravone combined with vinpocetine can notably improve the symptom of ACI patients.
结论：依达拉奉与长春西汀联用能显著提高急性脑梗死患者的疗效。
OBJECTIVE To investigate the pulmonary preservation effect of Edaravone on isolated rabbit lung.
目的探讨依达拉奉对离体兔肺脏保存质量的影响。
OBJECTIVE To determine the neuroprotective effect of edaravone on focal cerebral ischemia in rats.
目的探讨自由基清除剂依达拉奉对大鼠脑缺血及再灌注损伤的保护作用。
Conclusion Edaravone can accelerate the recovery of neural function after acute cerebral infarction.
结论依达拉奉可促进急性脑梗死患者的神经功能康复。
CONCLUSION Edaravone can accelerate the recovery of neural function after cerebral hemorrhage safely.
结论依达拉奉可促进脑出血患者的神经功能康复并较为安全。
Conclusion Edaravone is an effective and safe medicine in the treatment of acute cerebra1 infarction.
结论依达拉奉能够安全有效的治疗急性脑梗死。
Objective To assess the clinical efficacy and safety of Edaravone in treatment of acute cerebral infarction.
目的观察依达拉奉治疗急性脑梗塞的临床效果及安全性。
Rats in reperfusion group received physiologic saline with the same dose, method, time as the edaravone group.
再灌注组给予生理盐水，给药剂量、时间和方法同依达拉奉组。
Conclusion Edaravone therapy has been proven efficacious and safe in treating acute senile cerebral infarction.
结论依达拉奉治疗急性老年脑梗死安全、有效。
Objective To observe the clinical effect of large dose of naloxone plus edaravone on acute cerebral infarction.
目的探讨大剂量纳洛酮加依达拉奉治疗急性脑梗死的临床效果。
Results Incidence of symptomatic vasospasm was 14.63% in edaravone remedy; 36.59% in routine remedy respectively.
结果两组症状性血管痉挛发生率分别为：依达拉奉组14.63%，常规治疗组36.59%。
OBJECTIVE To evaluate the clinical efficacy and safety of edaravone in the treatment of acute cerebral infarction.
目的观察依达拉奉治疗急性脑梗死的临床疗效及安全性。
Objective:To verify the new production of edaravone injection in line with quality standards, to meet sales demand.
目的：为了验证新生产的依达拉奉注射液符合质量标准，达到销售要求。
Conclusion SXT and edaravone injection was safe and effective to treat vascular dementia after cerebral infarction.
结论疏血通注射液和依达拉奉注射液联合治疗脑梗死后血管性痴呆安全有效。
Edaravone as a free radical scavenger has broken the pessimistic situation in the invalid neuroprotective treatment.
自由基清除剂依达拉奉打破了神经保护治疗无效的悲观现状。
Objective To evaluate the efficacy and safety of Edaravone on veteran patients with acute senile cerebral infarction.
目的评价依达拉奉治疗急性老年脑梗死的临床疗效和安全性。
Conclusion Edaravone is safe and effective in the treatment of brain damage secondary to hypertension intracerebral hemorrhage.
结论依达拉奉对高血压脑出血继发性脑损伤的治疗是安全有效的。
Objective: To inquire the clinical effects and safety of edaravone injection in the treatment of traumatic cerebral infarction (TCI).
目的：探讨依达拉奉治疗外伤性脑梗死(TCI)的临床疗效和安全性。
Both the animal experiments and clinical trials have shown that edaravone is effective in the treatment of ischemia-reperfusion injury.
动物实验和临床试验表明，依达拉奉在治疗缺血再灌注损伤中的有效。
Objective To observe the clinical effect of naloxone joint edaravone on acute cerebrovascular disease with disturbance of consciousness.
目的观察纳洛酮联合依达拉奉治疗急性脑血管病意识障碍的疗效。
Simcere calls Bicun a "first-to-market, branded generic drug." Edaravone has been investigated heavily in Japan for use as a neuroprotectant.
先声称必存为“市场第一，品牌的仿制药。”在日本，对依达拉奉作为一种神经保护剂进行了大量研究。
Objective To investigate the therapeutic effect of edaravone on the promoting revival from coma and prognosis after acute severe head injury.
目的探讨依达拉奉注射液对急性重型颅脑损伤昏迷患者促醒作用以及对预后的影响。
CONCLUSION: Combining edaravone with breviscapine can effectively improve the neurological function and the living ability of patients with ACI.
结论：依达拉奉与灯盏花素联用能有效改善急性脑梗死患者的神经功能和生活能力。
Objective: to observe the effect of batroxobin in combined with edaravone to treat acute cerebral infarction patients and summarize its nursing.
观察巴曲酶联合依达拉奉治疗急性脑梗死的效果观察，总结其护理。
Objective To investigate the influence of edaravone on intestinal tissue ICAM-1 in intestinal barrier dysfunction after hemorrhagic shock of rabbits.
目的探讨依达拉奉在失血性休克中，对肠组织细胞间粘附分子- 1及肠屏障功能的影响。
Objective To investigate the influence of edaravone on intestinal tissue ICAM-1 in intestinal barrier dysfunction after hemorrhagic shock of rabbits.
目的探讨依达拉奉在失血性休克中，对肠组织细胞间粘附分子- 1及肠屏障功能的影响。
应用推荐